DEF 14A: AlTi Global Seeks Stockholder Approval for Allianz Investment, Board Nominees
Proxy Statement
AlTi Global is asking stockholders to vote on proposals related to an investment from Allianz, the election of directors, and an amendment to the company's certificate of incorporation at its upcoming annual meeting.
Summary
- AlTi Global is holding its 2024 Annual Meeting of Stockholders on June 26, 2024, virtually.
- Stockholders will vote on the election of six director nominees, the approval of a share issuance to Allianz Strategic Investments S..r.l., an amendment to the Certificate of Incorporation, and the ratification of KPMG LLP as the independent registered public accounting firm.
- The proposed amendment to the Certificate of Incorporation would authorize a new class of common stock, Class C Non-Voting Common Stock.
- The company is seeking approval for the issuance of shares of Class A Common Stock and Series A Preferred Stock to Allianz, including shares issuable upon conversion of the Series A Preferred Stock and exercise of warrants.
- The Board recommends voting FOR all proposals.
- Five directors, Craig Smith, Judy Lee, Nancy Curtin, Peter Yu and Spiros Maliagros will not be continuing on the Board of Directors after the Annual Meeting.
Sentiment
Score: 7
Explanation: The document is generally positive, outlining strategic initiatives and potential growth opportunities. However, it also acknowledges potential risks and dilutive effects, resulting in a moderate sentiment score.
Positives
- The Allianz investment is expected to provide capital for growth and strategic opportunities.
- The Board believes the Allianz transaction is the best available option for raising capital on favorable terms.
- The affiliation with Allianz is expected to help accelerate the company's strategic growth plan.
- The long-term nature of Allianz's investment, in the form of common stock and perpetual preferred stock, is a positive factor.
- The issuance and sale of Class A Common Stock will be at the current market price.
- The conversion prices are at a premium to both the current trading price of the company's Class A Common Stock and the volume weighted average price of such Class A Common Stock for the last 60 days.
Negatives
- The issuance of shares to Allianz will have a dilutive effect on existing stockholders.
- There is a risk that regulatory approvals are not obtained or that the Allianz transaction is not consummated.
- The restrictions on the conduct of the company's business prior to the Allianz Closing may delay or prevent the company from undertaking business opportunities.
- There is a potential for Allianz to acquire control, or be deemed to have effective control, of the company.
Risks
- Failure to obtain stockholder approval for the proposals could jeopardize the Allianz investment.
- The company's dependence on leverage by certain funds, underlying investment funds and portfolio companies and related volatility.
- The company's ability to successfully compete against other companies.
- Economic downturns and political and market conditions beyond the company's control could adversely affect the company's business.
Future Outlook
The company anticipates that the Allianz investment will enable it to execute its strategic plan and grow its business.
Management Comments
- Michael Tiedemann, Chief Executive Officer, thanks the directors who will not be continuing on the Board of Directors after the Annual Meeting.
- The company believes the virtual format encourages attendance and participation by a broader group of stockholders, while also reducing the costs and environmental impact associated with an in-person meeting.
Industry Context
The investment from Allianz reflects a trend of strategic partnerships between asset management firms and large financial institutions.
Comparison to Industry Standards
- The dividend rate on the Series A Preferred Stock is within the range of comparable preferred stock issuances in the financial services industry.
- The lock-up and transfer restrictions on the securities are consistent with standard practices in private placements.
Related Party Transactions
- The document details several related party transactions, including investor rights agreements, the Umbrella LLC Agreement, and the Tax Receivable Agreement.
- Certain directors and officers are members of Umbrella.
- The Tax Receivable Agreement provides for payments to TRA Recipients, including certain directors and officers, based on tax savings resulting from the Business Combination.
Stakeholder Impact
- The Allianz investment is expected to benefit shareholders by providing capital for growth and strategic opportunities.
- The issuance of shares to Allianz will have a dilutive effect on existing stockholders.
- The company's employees may benefit from the company's growth and strategic initiatives.
- The company's customers may benefit from the company's enhanced capabilities and services.
Next Steps
- Stockholders to vote on the proposals at the Annual Meeting on June 26, 2024.
- If approved, the company will proceed with the Allianz investment and implement the Charter Amendment.
- The company will file the Certificate of Designations for the Series B Preferred Stock with the Secretary of State of the State of Delaware.
Key Dates
| Date | Description |
|---|---|
| December 30, 2022 | Original Certificate of Incorporation of the Corporation filed with the Secretary of State of the State of Delaware |
| January 3, 2023 | Business Combination consummated |
| February 22, 2024 | Company entered into an Investment Agreement with Allianz |
| March 27, 2024 | Constellation Initial Closing occurred |
| May 1, 2024 | Record date for the Annual Meeting |
| May 10, 2024 | Mailing of Notice of Internet Availability of Proxy Materials to stockholders |
| June 26, 2024 | 2024 Annual Meeting of Stockholders |
| February 26, 2025 | Earliest date for receiving notice of intention to introduce a nomination or propose an item of business at the 2025 Annual Meeting |
| March 28, 2025 | Latest date for receiving notice of intention to introduce a nomination or propose an item of business at the 2025 Annual Meeting |
Keywords
Allianz, stockholders, investment, directors, Class A Common Stock, Series A Preferred Stock, Certificate of Incorporation, KPMG, proxy statement, annual meeting, capital raise, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.